SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-213840
Filing Date
2010-09-21
Accepted
2010-09-21 15:47:58
Documents
3
Period of Report
2010-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 23911
2 SUNESIS PHARMACEUTICALS, INC AMENDED AND RESTATED CHANGE OF CONTROL PAYMENT PLAN dex101.htm EX-10.1 94375
3 SUNESIS PHARMACEUTICALS, INC 2010 BONUS PROGRAM dex102.htm EX-10.2 16816
  Complete submission text file 0001193125-10-213840.txt   136892
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 101082657
SIC: 2834 Pharmaceutical Preparations